POLISCOPE
Back to feed
HR4883FEDERALIN_COMMITTEE
High Impact

Medicare Common Ownership Transparency Act of 2023

December 17, 2024

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

The bill aims to increase transparency regarding ''—where insurance plans, pharmacy benefit managers, and health care providers are owned by the same parent company—which may influence the costs and quality of care for millions of Medicare beneficiaries.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare Advantage organizations

Must submit new ownership and financial data to the Secretary of Health and Human Services every three years.

Prescription drug plan sponsors

Must disclose ownership information for affiliated pharmacies and pharmacy benefit managers.

Medicare Payment Advisory Commission

Required to conduct new, periodic research and report findings to Congress.

What changed

Current stage: IN_COMMITTEE.

What's next

Floor Vote.

Background

  • Mr. Murphy is a member of the U.S. House of Representatives. context
  • The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises the U.S. Congress on issues affecting the Medicare program. context

Summary

This bill requires Medicare Advantage plans and prescription drug plans to disclose ownership information for their affiliated health care providers and pharmacies. It also mandates that the Medicare Payment Advisory Commission (MedPAC) produce regular reports analyzing how this corporate ownership affects health care access, pricing, and patient outcomes.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

The bill aims to increase transparency regarding ''—where insurance plans, pharmacy benefit managers, and health care providers are owned by the same parent company—which may influence the costs and quality of care for millions of Medicare beneficiaries.

Frequently Asked Questions

What is 'vertical integration' in this context?
It refers to situations where a single parent company owns multiple parts of the health care supply chain, such as an insurance plan, a pharmacy benefit manager, and the pharmacies or doctors providing the care.
How often will these reports be required?
MA organizations and PDP sponsors must report ownership data every three years starting in 2025. MedPAC is required to submit its broader analysis to Congress every three years starting in 2029.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Vertical Integration

The bill signals a legislative shift toward investigating the financial relationships between insurers, PBMs, and providers, rather than just focusing on drug prices alone.

Connected Entities

organizationSecretaryThe Secretary of Health and Human ServicesMap →
organizationMedicare Advantage OrganizationsMA plans subject to disclosure requirementsMap →
organizationMedPACMedicare Payment Advisory CommissionMap →
organizationEnergy and Commerce CommitteeCommittee responsible for consideration of the billMap →
organizationWays and Means CommitteeCommittee responsible for consideration of the billMap →
organizationPDP SponsorsPDP sponsors subject to disclosure requirementsMap →
personMurphyIntroduced the bill in the House of RepresentativesMap →

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz25
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record